Downloads: 254

Files in This Item:
File Description SizeFormat 
1756-9966-28-9.pdf661.26 kBAdobe PDFView/Open
Title: Prognostic value of metastin expression in human pancreatic cancer.
Authors: Nagai, Kazuyuki
Doi, Ryuichiro
Katagiri, Fumihiko
Ito, Tatsuo  KAKEN_id
Kida, Atsushi
Koizumi, Masayuki
Masui, Toshihiko  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-4001-4824 (unconfirmed)
Kawaguchi, Yoshiya  kyouindb  KAKEN_id
Tomita, Kenji
Oishi, Shinya  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-2833-2539 (unconfirmed)
Fujii, Nobutaka  KAKEN_id
Uemoto, Shinji  kyouindb  KAKEN_id
Author's alias: 土井, 隆一郎
Issue Date: 21-Jan-2009
Publisher: BioMed Central Ltd.
Journal title: Journal of experimental & clinical cancer research : CR
Volume: 28
Thesis number: 9
Abstract: [Background]KiSS-1 was identified as a metastasis-suppressing gene in melanoma cells. The KiSS-1 gene product (metastin) was isolated from human placenta as the ligand of GPR54, a G-protein-coupled receptor. The role of metastin and GPR54 in tumor progression is not fully understood. [Methods]We investigated the clinical significance of metastin and GPR54 expression in pancreatic cancer. We evaluated immunohistochemical expression of metastin and GPR54 in pancreatic ductal adenocarcinoma tissues obtained from 53 consecutive patients who underwent resection between July 2003 and May 2007 at Kyoto University Hospital. In 23 consecutive patients, the plasma metastin level was measured before surgery by enzyme immunoassay. [Results]Strong immunohistochemical expression of metastin was detected in 13 tumors (24.5%), while strong expression of GPR54 was detected in 30 tumors (56.6%). Tumors that were negative for both metastin and GPR54 expression were significantly larger than tumors that were positive for either metastin or GPR54 (p = 0.047). Recurrence was less frequent in patients who had metastin-positive tumors compared with those who had metastin-negative tumors (38.5% versus 70.0%, p = 0.04). Strong expression of metastin and GPR54 was significantly correlated with longer survival (p = 0.02). Metastin expression by pancreatic cancer was an independent prognostic factor for longer survival (hazard ratio, 2.1; 95% confidence interval, 1.1–4.7; p = 0.03), and the patients with a high plasma metastin level (n = 6) did not die after surgical resection. [Conclusion]Strong expression of metastin and GPR54 by pancreatic cancer is associated with longer survival. Metastin expression is an independent prognostic factor for the survival of pancreatic cancer patients. The plasma metastin level could become a noninvasive prognostic factor for the assessment of pancreatic cancer.
Rights: © 2009 Nagai et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
URI: http://hdl.handle.net/2433/159721
DOI(Published Version): 10.1186/1756-9966-28-9
PubMed ID: 19154616
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.